These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18609436)

  • 21. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
    Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.
    Fava M; Wiltse C; Walker D; Brecht S; Chen A; Perahia D
    J Affect Disord; 2009 Mar; 113(3):263-71. PubMed ID: 18625521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of duloxetine in medico-legal death investigations in Victoria, Australia (2009-2012).
    Pilgrim JL; Gerostamoulos D; Drummer OH
    Forensic Sci Int; 2014 Jan; 234():165-73. PubMed ID: 24378318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
    Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
    Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
    Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
    J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of venlafaxine-induced bruxism alleviated by duloxetine substitution.
    Chang JP; Wu CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):307. PubMed ID: 21111016
    [No Abstract]   [Full Text] [Related]  

  • 32. [Brief case report. Duloxetine in Cotard syndrome].
    Kozian R
    Psychiatr Prax; 2005 Nov; 32(8):412-3. PubMed ID: 16342026
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute massive pulmonary thromboembolism due to acute intoxication by duloxetine: a case report.
    Mari F; Gualco B; Rensi R; Bertol E
    Cardiovasc Toxicol; 2012 Sep; 12(3):258-62. PubMed ID: 22351288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed salicylate toxicity with undetectable initial levels after large-dose aspirin ingestion.
    Herres J; Ryan D; Salzman M
    Am J Emerg Med; 2009 Nov; 27(9):1173.e1-3. PubMed ID: 19931787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of duloxetine self-administered in overdose with quetiapine and other antipsychotic drugs in a Japanese patient admitted to hospital.
    Adachi K; Beppu S; Nishiyama K; Shimizu M; Yamazaki H
    J Pharm Health Care Sci; 2021 Feb; 7(1):6. PubMed ID: 33531089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual presentation of sertraline and trazodone overdose.
    Adson DE; Erickson-Birkedahl S; Kotlyar M
    Ann Pharmacother; 2001 Nov; 35(11):1375-7. PubMed ID: 11724086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fatal case of potential chronic overdoses of prescribed and proprietary remedies.
    Takase I; Yamamoto Y; Nakagawa T; Nishi K
    Hum Exp Toxicol; 2010 Aug; 29(8):695-9. PubMed ID: 20106941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal overdose with a combination of SNRIs venlafaxine and duloxetine.
    Alibegović A; Kariž S; Volavšek M
    Forensic Sci Med Pathol; 2019 Jun; 15(2):258-261. PubMed ID: 30796754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdose.
    Taylor D; Lenox-Smith A; Bradley A
    Ther Adv Psychopharmacol; 2013 Jun; 3(3):151-61. PubMed ID: 24167687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt.
    Paulzen M; Hiemke C; Gründer G
    Int J Neuropsychopharmacol; 2009 Nov; 12(10):1431-2. PubMed ID: 19656434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.